image
Healthcare - Biotechnology - NASDAQ - US
$ 5.38
0.373 %
$ 48.3 M
Market Cap
-20.69
P/E
BALANCE SHEET
45.1 M ASSETS
2.95%
17.6 M LIABILITIES
-6.55%
26.4 M EQUITY
5.68%
BALANCE SHEET DECOMPOSITION
Balance Sheet ImmuCell Corporation
image
Current Assets 15 M
Cash & Short-Term Investments 3.76 M
Receivables 3.81 M
Other Current Assets 7.47 M
Non-Current Assets 30.1 M
Long-Term Investments 0
PP&E 29.9 M
Other Non-Current Assets 148 K
8.33 %8.45 %16.57 %66.32 %Total Assets$45.1m
Current Liabilities 4.41 B
Accounts Payable 0
Short-Term Debt 0
Other Current Liabilities 4.41 B
Non-Current Liabilities 8.76 B
Long-Term Debt 9.04 M
Other Non-Current Liabilities 8.75 B
33.50 %66.43 %Total Liabilities$13.2b

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990 Dec-1989
ASSETS
Cash & Cash Equivalents 3.8 1.0 5.8 10.2 7.9 8.8 2.5 3.8 5.2 1.6 0.9 2.3 2.7 0.8 1.4 1.0 1.2 1.2 1.3 1.2 1.7 3.4 2.4 1.9 1.9 1.8 1.5 1.0 1.0 1.6 1.3 1.5 1.1 0.8 0.9 0.6
Short Term Investments 0 0 0 468 1.0 2.5 0 0 5.5 4.5 2.5 3.0 2.2 4.2 3.2 3.6 3.9 4.2 5.3 3.9 2.7 0.9 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 3.8 2.2 1.8 2.7 1.9 1.7 1.4 1.5 1.1 0.7 1.0 0.6 0.6 0.4 0.5 0.4 0.9 0.9 0.6 0.7 0.4 0.4 0.4 1.0 0.9 0.5 0.2 0.7 0.4 0.4 0.4 0.4 0.2 100 K 0.2 0.3
Inventory 0 7.8 6.0 3.1 2.1 2.5 2.3 2.0 2.1 0.9 0.9 1.2 1.6 1.7 1.6 1.1 0.6 0.6 0.8 0.7 0.7 0.7 0.8 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.5 0.7 0.6 0.4 0.3
Other Current Assets 0 0.5 0.4 0.3 0.3 0.2 0.1 0.2 0.5 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.3 92 K 0.1 0.1 0.1 27.8 K 100 K 0 100 K 0 0 0.2 100 K 0.2 1.5 2.4
Total Current Assets 15.0 11.5 14.0 16.3 12.2 13.2 6.4 7.5 14.3 7.9 5.5 7.3 7.4 7.2 7.0 6.3 6.7 7.1 8.4 6.8 5.8 5.4 4.5 3.5 3.4 2.8 2.3 2.2 2.1 2.6 2.3 2.6 2.1 1.7 3.0 3.6
PP&E 29.9 32.1 30.6 28.0 28.0 25.3 26.0 26.1 9.8 5.7 3.8 2.5 2.4 2.5 2.7 3.0 2.9 2.9 1.9 1.8 1.9 1.8 1.7 1.7 0.9 0.8 0.7 0.8 0.8 0.7 0.8 0.5 0.2 0.2 0.3 0.2
Intangible Assets 0 38.2 K 57.3 K 76.4 K 95.5 K 0.1 0.1 0.2 0.2 0 0 0 0 0 0 900 31.9 K 66.7 K 0.5 0.8 1.1 0.2 0 0.3 0 0 0 0 0 0 0 0 0 100 K 100 K 100 K
Goodwill 0 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 40.2 K 0 0 0.5 0.5 0 0 0 0 0 0 (265.0) (316.2) (421.2) (459.2) (737.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 33.4 K 57.7 K 76.6 K 26.1 K 26.2 K 26.9 K 53.2 K 920 34.3 K 49.7 K 18.9 K 13.6 K 63.6 K 19 K 34 K 0 0 265.0 316.2 421.2 459.2 737.1 1.3 1.6 2.1 0.3 100 K 0.2 0.2 100 K 0 0 0 0.2 0 100 K
Other Assets 0 0 351 312 406 164 168 44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 45.1 43.8 44.9 44.5 40.4 38.7 32.7 34.3 24.7 14.6 11.1 11.0 11.0 11.0 10.8 10.0 10.1 10.4 11.4 10.0 9.5 8.2 7.5 7.1 6.4 3.9 3.1 3.2 3.1 3.2 3.1 3.1 2.3 2.2 3.4 4.0
LIABILITIES
Accounts Payable 0 0.9 0.8 0.7 0.6 0.4 0.6 0.6 1.5 0.2 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 92.7 K 61.6 K 86.8 K 0.2 0.2 0.3 100 K 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0 0
Short Term Debt 0 2.1 1.1 0.9 0.9 1.3 1.3 0.3 0.1 0.1 0.2 0.2 0.2 0.2 42.4 K 0 0 0 0 0 0 0 0 22.3 K 20.5 K 18.7 K 0 0.2 0.2 0.2 100 K 0 0 0.2 100 K 100 K
Other Current Liabilities 4 412.2 1.2 1.2 0.9 0.7 0.8 0.6 1.1 0.4 0.5 0.4 0.3 0.3 0.3 0.4 0.7 0.4 0.2 (239.2) (44.1) 0.2 0.4 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.4 0.4
Total Current Liabilities 4 412.2 4.2 3.1 2.5 2.2 2.5 2.6 2.1 2.1 0.8 1.0 0.6 0.7 0.6 0.5 0.4 0.5 0.4 1.4 0.7 0.8 0.4 0.3 0.6 0.5 0.6 0.4 0.6 0.7 0.7 0.6 0.4 0.5 0.7 0.5 0.5
Long Term Debt 9.0 14.6 11.4 9.4 9.9 7.1 8.4 8.6 2.9 3.1 0.7 0.9 1.1 1.3 0.9 0 0 0 0 0.7 1.0 0.4 0.3 0.4 0.4 0.4 0.5 0.3 0.6 0.6 0.6 0.4 0 0 100 K 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 19.6 1 230.3 1 154.7 1 246.0 0 4.8 0 0 340.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 8 748.8 0 0 0 0 58.5 K 0 996 37.3 K 78.5 K 38.8 K 33 K 83.4 K 67.9 K 0 0 0 (340.0) 0 0 0 0 0 0.1 0 0 0 0 100 K 0 0 0 0 0 0 100 K
Total Liabilities 17.6 18.8 14.5 11.9 12.1 9.7 11.0 10.7 5.0 4.0 1.8 1.6 1.8 2.0 1.5 0.4 0.5 0.4 2.0 1.4 1.8 0.8 0.6 1.1 0.9 1.0 0.9 0.9 1.2 1.3 1.2 0.8 0.5 0.7 0.6 0.6
EQUITY
Common Stock 904.2 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0 0 0 0 0 0 0 0 0 0
Retained Earnings (14.2) (12.0) (6.2) (3.7) (3.7) (2.6) (1.3) 1.0 1.1 0.6 (0.6) (0.4) (0.5) (0.6) (0.2) 0.2 0.4 0.9 0.2 (0.4) (0.6) (1.3) (1.7) (2.6) (3.0) (5.2) (5.8) (5.7) (5.9) (5.9) (5.9) (5.8) (5.7) (5.5) (4.1) (3.6)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 43.9 K 30.2 K 638 23.9 K 50.3 K 23.3 K 19.8 K 50.1 K 40.8 K 9.63 K (2.6) (2.3) (1.9) (2.0) (1.8) (1.5) (1.3) (1.1) (1.1) (1.0) (0.9) (0.8) (0.7) (0.6) (0.7) 0 0 0 0 0 0
Total Equity 26.4 25.0 30.4 32.6 28.3 29.0 21.7 23.6 19.7 10.6 9.3 9.4 9.2 9.0 9.3 9.6 9.6 10.1 9.3 8.6 7.7 7.4 7.0 6.0 5.5 2.8 2.2 2.3 1.9 1.9 1.9 2.3 1.8 1.5 2.8 3.4
Total Liabilities and Equity 45.1 43.8 44.9 44.5 40.4 38.7 32.7 34.3 24.7 14.6 11.1 11.0 11.0 11.0 10.8 10.0 10.1 10.4 11.4 10.0 9.5 8.2 7.5 7.1 6.4 3.9 3.1 3.2 3.1 3.2 3.1 3.1 2.3 2.2 3.4 4.0
SHARES OUTSTANDING
Common Shares Outstanding 8.2 7.7 7.7 7.6 7.2 6.8 5.5 4.9 4.2 3.0 3.0 3.0 3.0 3.0 3.0 3.0 2.9 2.9 2.9 2.8 2.8 2.7 2.8 2.8 2.6 2.4 2.4 2.7 2.7 2.3 1.7 2.6 1.8 2.0 2.1 2.0